Re:Vaccines Against H.I.V., Malaria and Tuberculosis Unlikel...
by craftyguy on Sunday September 16, 2018 @12:12PM
(#17999621)
> and in both cases due to rare strains with resistance to both drugs.
So then it is only a matter of time before we have 'super' HIV strains that are resistant running around. Perhaps it's not such a great idea to have large numbers of people exposing these drugs to the virus regularly, else we'll end up with more resistant strains..
Re:Vaccines Against H.I.V., Malaria and Tuberculosis Unlikel...
by matthewmacleod on Sunday September 16, 2018 @12:53PM
(#17999825)
I'm not a virologist, but my understanding is that the lifecycle of HIV makes that unlikely. An individual must be infected with the virus in order for drug resistance to emerge; using PReP prevents infection from happening in the first place by stopping viral replication. HIV is quite hard to transmit – someone who is not infected or who is on a stable treatment regime can't transmit the virus to anybody, so resistance isn't much of a concern there.
The bigger risk of drug-resistant strains emerging is due to poor adherence to medication regimes. Missing doses of antiretroviral therapy can cause drug resistance to emerge rapidly, as viral replication is no longer suppressed and HIV mutates like crazy.
It’s a combination of two antiretroviral drugs also used in HIV treatment (Tenofovir and Emtricitabine) and the effectiveness of it can’t really be overstated - my understanding is that there are only two documented cases of someone correctly using this drug becoming HIV-positive, and in both cases due to rare strains with resistance to both drugs.
It’s not a vaccine, but it does change the picture massively for at-risk groups.